These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17186022)

  • 1. Downregulation of Bid is associated with PKCepsilon-mediated TRAIL resistance.
    Sivaprasad U; Shankar E; Basu A
    Cell Death Differ; 2007 Apr; 14(4):851-60. PubMed ID: 17186022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer].
    Zhu HB; Huang XF; Hu JZ; Zhou W; Chen W; Chen LL; He C
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):245-9. PubMed ID: 18788624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex.
    Izeradjene K; Douglas L; Delaney AB; Houghton JA
    Cancer Res; 2004 Nov; 64(21):8036-44. PubMed ID: 15520213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C-epsilon protects MCF-7 cells from TNF-mediated cell death by inhibiting Bax translocation.
    Lu D; Sivaprasad U; Huang J; Shankar E; Morrow S; Basu A
    Apoptosis; 2007 Oct; 12(10):1893-900. PubMed ID: 17668322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genistein sensitizes human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by enhancing Bid cleavage.
    Jin CY; Park C; Moon SK; Kim GY; Kwon TK; Lee SJ; Kim WJ; Choi YH
    Anticancer Drugs; 2009 Sep; 20(8):713-22. PubMed ID: 19617819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
    Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria-dependent and -independent mechanisms in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis are both regulated by interferon-gamma in human breast tumour cells.
    Ruiz-Ruiz C; López-Rivas A
    Biochem J; 2002 Aug; 365(Pt 3):825-32. PubMed ID: 11936954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of the mitogen-activated protein kinase pathway antagonizes TRAIL-induced apoptosis downstream of BID cleavage in human breast cancer MCF-7 cells.
    Sarker M; Ruiz-Ruiz C; Robledo G; López-Rivas A
    Oncogene; 2002 Jun; 21(27):4323-7. PubMed ID: 12082620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death.
    Meslin F; Hamaï A; Gao P; Jalil A; Cahuzac N; Chouaib S; Mehrpour M
    Cancer Res; 2007 Nov; 67(22):10910-9. PubMed ID: 18006836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mitogen-activated protein kinase pathway can inhibit TRAIL-induced apoptosis by prohibiting association of truncated Bid with mitochondria.
    Ortiz-Ferrón G; Tait SW; Robledo G; de Vries E; Borst J; López-Rivas A
    Cell Death Differ; 2006 Nov; 13(11):1857-65. PubMed ID: 16485030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis.
    Chawla-Sarkar M; Bae SI; Reu FJ; Jacobs BS; Lindner DJ; Borden EC
    Cell Death Differ; 2004 Aug; 11(8):915-23. PubMed ID: 15118763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.
    Fulda S; Meyer E; Debatin KM
    Oncogene; 2002 Apr; 21(15):2283-94. PubMed ID: 11948412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
    Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response.
    Jiang CC; Chen LH; Gillespie S; Kiejda KA; Mhaidat N; Wang YF; Thorne R; Zhang XD; Hersey P
    Cancer Res; 2007 Jun; 67(12):5880-8. PubMed ID: 17575157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bid is cleaved upstream of caspase-8 activation during TRAIL-mediated apoptosis in human osteosarcoma cells.
    Garnett TO; Filippova M; Duerksen-Hughes PJ
    Apoptosis; 2007 Jul; 12(7):1299-315. PubMed ID: 17431792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma.
    Ndozangue-Touriguine O; Sebbagh M; Mérino D; Micheau O; Bertoglio J; Bréard J
    Oncogene; 2008 Oct; 27(46):6012-22. PubMed ID: 18560353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of Bid and Bax in indirubin-3'-monoxime-induced apoptosis in human cancer cells.
    Shi J; Shen HM
    Biochem Pharmacol; 2008 May; 75(9):1729-42. PubMed ID: 18377873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired kinetics of Bax-GFP and Smac/DIABLO-GFP in caspase-8- and bid-silenced and Bcl-2 overexpressed breast cancer MCF-7 cells exposed to camptothecin.
    Górka M; Lamparska-Przybysz M; Motyl T
    Cell Mol Biol (Noisy-le-grand); 2007 Jan; 52 Suppl():OL915-22. PubMed ID: 17666167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4.
    Kurbanov BM; Fecker LF; Geilen CC; Sterry W; Eberle J
    Oncogene; 2007 May; 26(23):3364-77. PubMed ID: 17160022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
    Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
    Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.